Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework

Human papillomavirus (HPV) assays used in cervical cancer screening should be clinically validated according to international criteria. OncoPredict HPV® Screening (SCR) is a partial genotyping multiplex real‐time PCR assay targeting E6/E7 genes of 13 high‐risk (hr) HPVs. OncoPredict HPV® SCR (index...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhillon, Sharonjit K., Cocuzza, Clementina E., Chung, Pui Yan Jenny, Martinelli, Marianna, Giubbi, Chiara, Njoku, Ruth C., Bhatia, Ramya, Cuschieri, Kate, Arbyn, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107715/
https://www.ncbi.nlm.nih.gov/pubmed/36541733
http://dx.doi.org/10.1002/jmv.28417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107715/
https://www.ncbi.nlm.nih.gov/pubmed/36541733
http://dx.doi.org/10.1002/jmv.28417

Ejemplares similares